CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 79 enrolled
Drug / intervention
D-Cycloserine (DCS) +1 moredrug
Likely dose
D-Cycloserine (DCS) 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00759473
NCT00759473Phase 2Completed
CompareCT.gov

D-Cycloserine Facilitation of Cocaine - Cue Extinction

Medical University of South Carolina·interventional·Posted Sep 25, 2008·Updated Apr 13, 2016

In Brief

A Phase 2 clinical trial evaluating D-Cycloserine (DCS) and Placebo for Cocaine Use Disorders. Completed, enrolled 79 participants across 2 sites.

Detailed Summary

The purpose of this study is to explore the use of d-cycloserine (DCS) to facilitate extinction of response to cocaine cues in cocaine-dependent individuals, in hopes that it may lead to the development of new treatment options for cocaine dependence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Use Disorders
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 25, 2008
Enrollment StartSep 1, 2008
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 17.8 years ago

Interventions

D-Cycloserine (DCS)drug

50 mg d-cycloserine or placebo taken orally

Placebodrug